Community-Based Management and Treatment Services for Psychosis — China, 2019

Zhao, Miaomiao; Ma, Ning; Wang, Xun; Wu, Xiamin; Zhang, Wufang; Chen, Runzi; Wang, Yulu; Guan, Lili; Ma, Hong; Yu, Xin; Lü, Lin

doi:10.46234/ccdcw2020.217

Cited by 4 publications

(4 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The randomization processes of sub-districts to intervention and control arms are as follows: (1) The sociodemographic characteristics and specific information of patients with schizophrenia of each sub-district will be obtained from the information system [11]; (2) A pairwise matching work will be conducted to identify 9 pairs of matched sub-district that share similar characteristics (number of population, prevalence of schizophrenia, average income per capita, etc. ); (3) Within each pair, one sub-district will be randomly assigned into intervention arm, and the remaining one will be assigned into control arm, yielding to 9 sub-districts in intervention arm that providing FBC + CBR, and 9 sub-districts in control arm with FBC only.…”

Section: Allocationmentioning

confidence: 99%

Community-based rehabilitation interventions on quality of care for people with schizophrenia in China (CRISC): study protocol for a cluster-randomized controlled trial

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background International consensus shows that community-based rehabilitation (CBR) service is an effective way to improve functioning and negative symptoms and address the treatment gap for schizophrenia. Rigorous trials are needed in China to demonstrate effective and scalable CBR interventions to significantly improve outcomes for people with schizophrenia and to provide evidence of the economic benefits. The objectives of this trial are to examine the effectiveness of CBR as an adjunct to test the usual facility-cased care (FBC) in comparison to FBC alone in improving a range of outcomes in people with schizophrenia and their caregivers. Methods This trial is a cluster randomized controlled trial design in China. The trial will be conducted at three districts of Weifang city, Shandong province. Eligible participants will be identified from the psychiatric management system where community-dwelling patients with schizophrenia have been registered. Participants will be recruited after providing informed consent. 18 sub-districts will be randomly allocated in a 1:1 ratio to facility-based care (FBC) plus CBR (intervention arm) or FBC alone (control arm). The structured CBR intervention will be delivered by trained psychiatric nurses or community health workers. We aim to recruit 264 participants. The primary outcomes include symptoms of schizophrenia, personal and social function, quality of life, family burden of caring, etc. The study will be conducted according to good ethical practice, data analysis and reporting guidelines. Discussion If the hypothesized clinical benefit and cost-effectiveness of CBR intervention are confirmed, this trial will provide significant implications for policy makers and practitioners to scale up rehabilitation services, as well as for people with schizophrenia and their family to promote recovery and social inclusion, and to alleviate the burden of care. Trial registration Chinese Clinical Trial Registry (ChiCTR2200066945). Registered December 22, 2022.

show abstract

Section: Allocationmentioning

confidence: 99%

Community-based rehabilitation interventions on quality of care for people with schizophrenia in China (CRISC): study protocol for a cluster-randomized controlled trial

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…From 2001 to 2020, community-based mental health services developed rapidly in Shanghai. Patients had the highest regular management rate and stable rate,26 with a much lower Gini coefficient in China than in other countries 27. The prevalence of schizophrenia in China has more than doubled since 2010, with particularly high rates observed in the most developed areas of modern China; moreover, the prevalence of schizophrenia is still increasing 28.…”

Section: Introductionmentioning

confidence: 99%

Shanghai Community-Based Schizophrenia Cohort (SCS): a protocol for establishing a longitudinal cohort and research database of patients with schizophrenia receiving community-based mental health treatment

Zhu,

He,

Liu

et al. 2024

BMJ Open

View full text Add to dashboard Cite

IntroductionDrivers for remission, relapse and violence-related behaviour among patients with schizophrenia are the most complicated issue.Methods and analysisThis study aims to recruit a longitudinal cohort of patients with schizophrenia. Two suburban districts and two urban districts were randomly selected according to health service facilities, population, geographical region and socioeconomic status. Individuals (>18 years old) who received a diagnosis of schizophrenia following the International Classification of Diseases (10th edition) criteria within the past 3 years will be invited as participants. Assessments will be carried out in local community health centres. Data will be used to (1) establish a community-based schizophrenia cohort and biobank, (2) prospectively determine the course of multidimensional functional outcomes of patients with schizophrenia who are receiving community-based mental health treatment, and (3) map the trajectories of patients with schizophrenia and prospectively determine the course of multidimensional outcomes based on the differential impact of potentially modifiable moderators.Ethics and disseminationThe study has been reviewed and approved by the Human Research Ethics Committee of Shanghai Mental Health Center (2021-67). Results of the study will be disseminated through peer-reviewed journals. If effective, related educational materials will be released to the public.

show abstract

“…The weighted lifetime prevalence of schizophrenia is 0.6% in China [ 1 ]. As of 2019, approximately 4.5 million schizophrenia patients were registered in China, with the majority being patients dwelling and managed in communities [ 2 ]. Many of these community-dwelling patients lived in rural areas [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

“…As of 2019, approximately 4.5 million schizophrenia patients were registered in China, with the majority being patients dwelling and managed in communities [ 2 ]. Many of these community-dwelling patients lived in rural areas [ 2 ]. In China, patients with severe mental disorder, whether in a rural or urban community, receive free medication and community-based mental health services [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Association between social support and the severity of positive symptoms in rural community-dwelling patients with schizophrenia during the COVID-19 pandemic

Liu,

Chen

et al. 2024

BMC Psychiatry

View full text Add to dashboard Cite

Background This study examined the association between social support and the severity of positive symptoms in rural community-dwelling schizophrenia patients during the COVID-19 pandemic. Method The cross-sectional study included 665 rural community-dwelling schizophrenia patients investigated during the COVID-19 pandemic. Social support was measured using the Social Support Rating Scale, and positive symptoms were assessed using the Positive Scale extracted from the Positive and Negative Syndrome Scale. Multiple linear regression was adopted to examine the association of social support with positive symptoms. Result The scores for total social support, subjective support, objective support and the use of social support were 28.3 ± 5.9, 16.4 ± 5.2, 6.5 ± 1.4 and 5.4 ± 2.8, respectively. Total social support (β = −0.08, 95%CI: −0.13 to −0.02, P < 0.01) and subjective social support (β = −0.10, 95%CI: −0.16 to −0.04, P < 0.01) were significantly and negatively associated with the Positive Scale score after adjustment for confounders. Objective social support (β = 0.11, 95%CI: −0.10 to 0.32, P = 0.31) and the use of social support (β = −0.03, 95%CI: −0.14 to 0.07, P = 0.53) were not significantly associated with the Positive Scale score. Conclusion The study confirmed the importance of social support, especially subjective support, provided to rural community-dwelling schizophrenia patients during the COVID-19 pandemic. This support should be addressed and strengthened for such patients in emergent events.

show abstract

Community-Based Management and Treatment Services for Psychosis — China, 2019

Cited by 4 publications

References 2 publications

Community-based rehabilitation interventions on quality of care for people with schizophrenia in China (CRISC): study protocol for a cluster-randomized controlled trial

Community-based rehabilitation interventions on quality of care for people with schizophrenia in China (CRISC): study protocol for a cluster-randomized controlled trial

Shanghai Community-Based Schizophrenia Cohort (SCS): a protocol for establishing a longitudinal cohort and research database of patients with schizophrenia receiving community-based mental health treatment

Association between social support and the severity of positive symptoms in rural community-dwelling patients with schizophrenia during the COVID-19 pandemic

Contact Info

Product

Resources

About